Zacks Research Issues Positive Forecast for MD Earnings

Pediatrix Medical Group, Inc. (NYSE:MD) – Research analysts at Zacks Research upped their Q2 2025 earnings per share (EPS) estimates for shares of Pediatrix Medical Group in a report issued on Monday, March 10th. Zacks Research analyst Z. Masood now expects that the company will post earnings of $0.39 per share for the quarter, up from their previous estimate of $0.38. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group’s FY2025 earnings at $1.41 EPS, Q3 2026 earnings at $0.37 EPS and FY2027 earnings at $1.26 EPS.

A number of other research analysts have also commented on MD. Mizuho upped their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Tuesday, November 19th. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. UBS Group upped their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. Macquarie began coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price for the company. Finally, Truist Financial upped their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and a consensus target price of $17.08.

Pediatrix Medical Group Stock Down 0.8 %

MD opened at $13.93 on Wednesday. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $1.20 billion, a price-to-earnings ratio of -11.60, a P/E/G ratio of 1.74 and a beta of 1.48. The business has a 50 day moving average of $14.12 and a 200-day moving average of $13.37.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of MD. Nomura Asset Management Co. Ltd. raised its stake in Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after acquiring an additional 1,220 shares in the last quarter. Quest Partners LLC raised its stake in Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after acquiring an additional 1,040 shares in the last quarter. Quarry LP increased its stake in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after buying an additional 1,662 shares in the last quarter. Finally, AlphaQuest LLC increased its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after buying an additional 2,012 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.